15
Participants
Start Date
August 1, 2024
Primary Completion Date
September 1, 2024
Study Completion Date
November 1, 2024
Septicyte Lab Test pre operative
"SeptiCyte® technology uses proprietary biomarker signatures to assess the response of a patient's immune system to infections. It provides a score which can be used to differentiate sepsis from systemic inflammatory response.~Each included patient will received the Septicyte LAB test before and after surgery for acute mesenteric ischemia suspicion. The results will be compared to standard of care, retrospectively."
Septicyte Lab Test post operative
"SeptiCyte® technology uses proprietary biomarker signatures to assess the response of a patient's immune system to infections. It provides a score which can be used to differentiate sepsis from systemic inflammatory response.~Each included patient will received the Septicyte LAB test before and after surgery for acute mesenteric ischemia suspicion. The results will be compared to standard of care, retrospectively."
CHRU de Nancy, Nancy
Central Hospital, Nancy, France
OTHER